Anavex Market Capitalization from 2010 to 2024
| AVXL Stock | USD 9.03 0.01 0.11% |
Check Anavex Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anavex Life's main balance sheet or income statement drivers, such as Interest Expense of 1.3 M, Other Operating Expenses of 67.3 M or Total Operating Expenses of 67.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 3.48. Anavex financial statements analysis is a perfect complement when working with Anavex Life Valuation or Volatility modules.
Anavex | Market Capitalization |
Latest Anavex Life's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Anavex Life Sciences over the last few years. It is Anavex Life's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Anavex Life's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 766.13 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Anavex Market Capitalization Regression Statistics
| Arithmetic Mean | 274,686,874 | |
| Geometric Mean | 133,092,320 | |
| Coefficient Of Variation | 99.00 | |
| Mean Deviation | 226,774,638 | |
| Median | 154,544,445 | |
| Standard Deviation | 271,943,937 | |
| Sample Variance | 73953.5T | |
| Range | 786.5M | |
| R-Value | 0.80 | |
| Mean Square Error | 28203.2T | |
| R-Squared | 0.65 | |
| Significance | 0.0003 | |
| Slope | 48,869,627 | |
| Total Sum of Squares | 1035349.1T |
Anavex Market Capitalization History
About Anavex Life Financial Statements
Anavex Life investors utilize fundamental indicators, such as Market Capitalization, to predict how Anavex Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system diseases. The company was incorporated in 2004 and is headquartered in New York, New York. Anavex Lf operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 38 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Anavex Life Correlation against competitors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Return On Assets (0.20) | Return On Equity (0.30) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.